MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in MoonLake Immunotherapeutics as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +10 vs. Q3 2024
- Shares held
- 63.4M
- +1.29M (+2.1%) vs. Q3 2024
- Total value
- $3.43B
- +$301.6M (+9.6%) vs. Q3 2024
- New holders
- 23
- 48 more added
- Sold out
- 13
- 31 more reduced
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hood River Capital Management LLC | 649,590 | $35.2M | 0.52% | +2,928+0.5% | Added |
| Fred Alger Management, LLC | 673,773 | $36.5M | 0.17% | +7,199+1.1% | Added |
| Alliancebernstein L.P. | 1,022,604 | $55.4M | 0.02% | +24,464+2.5% | Added |
| Polar Capital Holdings Plc | 1,100,000 | $59.6M | 0.33% | +600,000+120.0% | Added |
| Marshall Wace, LLP | 1,245,299 | $67.4M | 0.08% | +90,914+7.9% | Added |
| Federated Hermes, Inc. | 1,280,052 | $69.3M | 0.15% | +149,724+13.2% | Added |
| Westfield Capital Management Co LP | 1,311,619 | $71.0M | 0.31% | +144,261+12.4% | Added |
| Holocene Advisors, LP | 1,585,167 | $85.8M | 0.28% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,674,664 | $90.7M | 0.02% | +178,833+12.0% | Added |
| Paradigm Biocapital Advisors LP | 1,772,211 | $96.0M | 3.34% | +840,731+90.3% | Added |
| Citadel Advisors LLC | 2,186,866 | $118.4M | 0.11% | −136,105−5.9% | Reduced |
| Avoro Capital Advisors LLC | 2,770,100 | $150.0M | 2.12% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,343,643 | $181.1M | 0.02% | +363,394+12.2% | Added |
| FMR LLC | 6,341,391 | $343.4M | 0.02% | +1,391,167+28.1% | Added |
| Cormorant Asset Management, LP | 8,494,151 | $460.0M | 25.26% | 00.0% | Unchanged |
| BVF Inc | 19,751,284 | $1.07B | 36.25% | −2,000,000−9.2% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −51,267−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −31,840−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −25,523−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −22,127−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −16,855−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −16,162−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,592−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −6,402−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,672−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |
| PEAK6 Investments LLC | – | – | – | – | Not filed |
| Planning Capital Management Corp | – | – | – | – | Not filed |